The Andhra Petrochemicals Limited has confirmed that its manufacturing plant will restart operations effective August 5, 2026. This resumption marks a significant operational milestone for the West Godavari-based entity, ending a period of inactivity referenced in earlier disclosures. The immediate restart aims to restore production capabilities and address supply chain continuity for its stakeholders.

The announcement was formally communicated to The Bombay Stock Exchange Ltd. on August 4, 2026. G. Adinarayana, CFO & Company Secretary of The Andhra Petrochemicals Limited, signed the intimation letter, which cites Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references a previous correspondence dated March 17, 2026, indicating that this restart follows a prolonged planning or maintenance phase.

Operational Timeline

The key dates surrounding the operational restart are detailed below:

Regulatory Compliance

The company ensured timely disclosure by submitting the intimation to the exchange on the day preceding the actual restart. Adherence to Regulation 30 of the SEBI LODR Regulations mandates such continuous disclosure obligations for listed entities to ensure market transparency. The specific reference to the March 17, 2026 letter suggests that investors were previously aware of the planned downtime or maintenance schedule, with this current filing serving as the final confirmation of the resumption date.

What This Means for Investors

The restart of plant operations is a material development for shareholders, as it signals the potential return of revenue generation from the affected facility. For a manufacturing entity like The Andhra Petrochemicals Limited, operational continuity is directly linked to cash flow stability and order fulfillment capacity. The precise dating of the restart allows downstream customers and suppliers to adjust their logistics and inventory planning accordingly. While the filing does not specify the expected output volume or the duration of the preceding shutdown, the definitive nature of the "w.e.f. 5th August, 2026" statement provides clarity on the immediate operational status.

Investors should monitor subsequent quarterly results to assess the impact of this restart on revenue figures and operating margins. The gap between the March disclosure and the August restart implies a substantial period of non-operation, making the efficiency of the ramp-up phase a critical factor in near-term financial performance.

Andhra Petrochemicals has confirmed the cessation of Dr. Pamidi Kotaiah from its Board of Directors following his death on the night of July 23, 2026. The company informed the Bombay Stock Exchange that Dr. Kotaiah’s roles as Chairman and Director ended effective July 24, 2026, marking a significant leadership transition for the West Godavari-based chemical manufacturer.

The intimation was issued under Clause 30 of the SEBI (LODR) Regulations, 2015, which mandates disclosure of changes in the composition of the Board. Dr. Pamidi Kotaiah, identified by DIN 00038420, served as a Non-Executive and Independent Director. His departure leaves a vacancy in the company's top leadership structure, requiring future board action to appoint a successor in compliance with regulatory norms for independent director representation.

Key Details of Cessation

The company provided specific details regarding the timeline and regulatory basis for the exit in its filing to the exchange.

The notice was signed by G. Adinarayana, who holds the dual role of Chief Financial Officer and Company Secretary at Andhra Petrochemicals. The filing was digitally signed and submitted on July 24, 2026, at 11:44:11 AM.

Impact on Corporate Governance

As an Independent Director, Dr. Kotaiah played a critical role in the company’s governance framework, providing oversight independent of management. His sudden passing necessitates an immediate review of the board’s composition to ensure continued compliance with the minimum requirements for independent directors stipulated by SEBI regulations. Shareholders may expect a subsequent announcement regarding the nomination or appointment of a new Independent Director to fill this vacancy.

The company expressed profound grief over the loss, describing it as a significant event for the organization. No further operational or financial details were disclosed in this specific regulatory filing, which focused solely on the personnel change.